irinotecan has been researched along with iodine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ewis, HE; Liu, P; Lu, CD; Tai, PC; Weber, IT | 1 |
Fukushima, K; Fukushima, S; Hata, A; Irie, K; Kaji, R; Katakami, N; Masuda, Y; Okada, A; Okada, Y; Okuda, C; Sugioka, N | 1 |
Ishikura, K; Mizukami, Y; Okuyama, H; Tamura, K | 1 |
3 other study(ies) available for irinotecan and iodine
Article | Year |
---|---|
Crystal structure of the Geobacillus stearothermophilus carboxylesterase Est55 and its activation of prodrug CPT-11.
Topics: Antineoplastic Agents, Phytogenic; Bacillaceae; Binding Sites; Camptothecin; Carboxylesterase; Crystallization; Crystallography; Cysteine; Iodine; Irinotecan; Models, Molecular; Prodrugs; Protein Conformation | 2007 |
Assessment of exposure risk of irinotecan and its active metabolite, SN-38, through perspiration during chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Glucuronosyltransferase; Humans; Irinotecan; Male; Middle Aged; Neoplasms; Sweat; Topoisomerase I Inhibitors | 2019 |
[Factors Affecting Development of Cholinergic Symptoms after Irinotecan Administration].
Topics: Abdominal Pain; Aged; Antineoplastic Agents, Phytogenic; Camptothecin; Cholinergic Agents; Female; Humans; Irinotecan; Male; Middle Aged; Neoplasms; Retrospective Studies; Sweat | 2018 |